MedPath

Abnormal Coronary Vasomotion in Patients With Suspected Coronary Artery Disease (CAD)

Not Applicable
Recruiting
Conditions
Coronary Vasospasm
Microvascular Angina
Coronary Artery Disease
Interventions
Other: Intracoronary acetylcholine provocation test
Registration Number
NCT00921856
Lead Sponsor
Peter Ong, MD
Brief Summary

In patients with chest pain and/or shortness of breath coronary artery disease (CAD) is suspected depending on the pattern of symptoms and the electrocardiogram (ECG). Coronary angiography is the method of choice to verify this suspicion. If the patient coronary arteries on coronary angiography are totally normal or unobstructed, one can only speculate if the patients' discomfort is from the heart or not. A possibility to get further information about the healthiness of the coronary arteries is the acetylcholine test (ACH-test). When injecting this natural, body produced-substance into the coronary arteries one can test if the vessels develop coronary spasm which can be the reason for the patient's symptoms. The investigators therefore use this test in this study to look for coronary spasm in patients with suspected CAD but normal/unobstructed coronary arteries. In case of a positive test, the patient profits from having found a cause for his/her symptoms making treatment with special tablets possible. Furthermore, the investigators want to analyze blood samples of every patient to look for signs of inflammation, vasoconstriction and genetic variants that seem to be linked with coronary spasms. On the basis of these results the ACH-test could probably be avoided in the future.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Adults between 35 and 95 years old with angina pectoris and/or dyspnea suggestive of coronary artery disease with non-invasive proof of coronary ischemia or high pre-test probability for CAD who will be referred for coronary angiography
  • Serum creatinine < 1,4 md/dl
  • Left ventricular ejection fraction > 50%
Exclusion Criteria
  • Patients under 35 years and above 95 years of age
  • Severe chronic obstructive pulmonary disease (contraindication for acetylcholine-testing)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
No-CADIntracoronary acetylcholine provocation testPatients admitted with suspicion of CAD but without proof of CAD after coronary angiography will undergo intracoronary acetylcholine provocation test.
Primary Outcome Measures
NameTimeMethod
all cause mortality (cardiac vs. non-cardiac)12-120 months
Secondary Outcome Measures
NameTimeMethod
Angina pectoris, repeated angiography, re-admissions for angina pectoris12-120 months

Trial Locations

Locations (1)

Robert Bosch Medical Center

🇩🇪

Stuttgart, Germany

© Copyright 2025. All Rights Reserved by MedPath